273 related articles for article (PubMed ID: 24534472)
1. Regulation of protein conformation by Pin1 offers novel disease mechanisms and therapeutic approaches in Alzheimer's disease.
Driver JA; Zhou XZ; Lu KP
Discov Med; 2014 Feb; 17(92):93-9. PubMed ID: 24534472
[TBL] [Abstract][Full Text] [Related]
2. The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production.
Pastorino L; Sun A; Lu PJ; Zhou XZ; Balastik M; Finn G; Wulf G; Lim J; Li SH; Li X; Xia W; Nicholson LK; Lu KP
Nature; 2006 Mar; 440(7083):528-34. PubMed ID: 16554819
[TBL] [Abstract][Full Text] [Related]
3. Distinct functions of cis and trans phosphorylated tau in Alzheimer's disease and their therapeutic implications.
Nakamura K; Zhou XZ; Lu KP
Curr Mol Med; 2013 Aug; 13(7):1098-109. PubMed ID: 23157676
[TBL] [Abstract][Full Text] [Related]
4. Pin1 dysregulation helps to explain the inverse association between cancer and Alzheimer's disease.
Driver JA; Zhou XZ; Lu KP
Biochim Biophys Acta; 2015 Oct; 1850(10):2069-76. PubMed ID: 25583562
[TBL] [Abstract][Full Text] [Related]
5. Cancer and Alzheimer's disease inverse relationship: an age-associated diverging derailment of shared pathways.
Lanni C; Masi M; Racchi M; Govoni S
Mol Psychiatry; 2021 Jan; 26(1):280-295. PubMed ID: 32382138
[TBL] [Abstract][Full Text] [Related]
6. Granular expression of prolyl-peptidyl isomerase PIN1 is a constant and specific feature of Alzheimer's disease pathology and is independent of tau, Aβ and TDP-43 pathology.
Dakson A; Yokota O; Esiri M; Bigio EH; Horan M; Pendleton N; Richardson A; Neary D; Snowden JS; Robinson A; Davidson YS; Mann DM
Acta Neuropathol; 2011 May; 121(5):635-49. PubMed ID: 21243369
[TBL] [Abstract][Full Text] [Related]
7. Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration.
Liou YC; Sun A; Ryo A; Zhou XZ; Yu ZX; Huang HK; Uchida T; Bronson R; Bing G; Li X; Hunter T; Lu KP
Nature; 2003 Jul; 424(6948):556-61. PubMed ID: 12891359
[TBL] [Abstract][Full Text] [Related]
8. Pin1 cysteine-113 oxidation inhibits its catalytic activity and cellular function in Alzheimer's disease.
Chen CH; Li W; Sultana R; You MH; Kondo A; Shahpasand K; Kim BM; Luo ML; Nechama M; Lin YM; Yao Y; Lee TH; Zhou XZ; Swomley AM; Butterfield DA; Zhang Y; Lu KP
Neurobiol Dis; 2015 Apr; 76():13-23. PubMed ID: 25576397
[TBL] [Abstract][Full Text] [Related]
9. Pin1 in Alzheimer's disease: multiple substrates, one regulatory mechanism?
Balastik M; Lim J; Pastorino L; Lu KP
Biochim Biophys Acta; 2007 Apr; 1772(4):422-9. PubMed ID: 17317113
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation-dependent prolyl isomerization: a novel signaling regulatory mechanism.
Zhou XZ; Lu PJ; Wulf G; Lu KP
Cell Mol Life Sci; 1999 Nov; 56(9-10):788-806. PubMed ID: 11212339
[TBL] [Abstract][Full Text] [Related]
11. Prolyl isomerase, Pin1: new findings of post-translational modifications and physiological substrates in cancer, asthma and Alzheimer's disease.
Takahashi K; Uchida C; Shin RW; Shimazaki K; Uchida T
Cell Mol Life Sci; 2008 Feb; 65(3):359-75. PubMed ID: 17965833
[TBL] [Abstract][Full Text] [Related]
12. Utilizing the peptidyl-prolyl cis-trans isomerase pin1 as a probe of its phosphorylated target proteins. Examples of binding to nuclear proteins in a human kidney cell line and to tau in Alzheimer's diseased brain.
Thorpe JR; Morley SJ; Rulten SL
J Histochem Cytochem; 2001 Jan; 49(1):97-108. PubMed ID: 11118482
[TBL] [Abstract][Full Text] [Related]
13. Pin1 in Alzheimer's disease.
Butterfield DA; Abdul HM; Opii W; Newman SF; Joshi G; Ansari MA; Sultana R
J Neurochem; 2006 Sep; 98(6):1697-706. PubMed ID: 16945100
[TBL] [Abstract][Full Text] [Related]
14. Prolyl isomerase Pin1 promotes amyloid precursor protein (APP) turnover by inhibiting glycogen synthase kinase-3β (GSK3β) activity: novel mechanism for Pin1 to protect against Alzheimer disease.
Ma SL; Pastorino L; Zhou XZ; Lu KP
J Biol Chem; 2012 Mar; 287(10):6969-73. PubMed ID: 22184106
[TBL] [Abstract][Full Text] [Related]
15. DNA sequence variations in the prolyl isomerase Pin1 gene and Alzheimer's disease.
Poli M; Gatta LB; Dominici R; Lovati C; Mariani C; Albertini A; Finazzi D
Neurosci Lett; 2005 Dec; 389(2):66-70. PubMed ID: 16095818
[TBL] [Abstract][Full Text] [Related]
16. Pin1 promotes degradation of Smad proteins and their interaction with phosphorylated tau in Alzheimer's disease.
Ueberham U; Rohn S; Ueberham E; Wodischeck S; Hilbrich I; Holzer M; Brückner MK; Gruschka H; Arendt T
Neuropathol Appl Neurobiol; 2014 Dec; 40(7):815-32. PubMed ID: 24964035
[TBL] [Abstract][Full Text] [Related]
17. Configuration-specific immunotherapy targeting cis pThr231-Pro232 tau for Alzheimer disease.
Wang JZ; Zhang Y
J Neurol Sci; 2015 Jan; 348(1-2):253-5. PubMed ID: 25467137
[TBL] [Abstract][Full Text] [Related]
18. Proline isomer-specific antibodies reveal the early pathogenic tau conformation in Alzheimer's disease.
Nakamura K; Greenwood A; Binder L; Bigio EH; Denial S; Nicholson L; Zhou XZ; Lu KP
Cell; 2012 Mar; 149(1):232-44. PubMed ID: 22464332
[TBL] [Abstract][Full Text] [Related]
19. Pinning down phosphorylated tau and tauopathies.
Lim J; Lu KP
Biochim Biophys Acta; 2005 Jan; 1739(2-3):311-22. PubMed ID: 15615648
[TBL] [Abstract][Full Text] [Related]
20. Tau pathology modulates Pin1 post-translational modifications and may be relevant as biomarker.
Ando K; Dourlen P; Sambo AV; Bretteville A; Bélarbi K; Vingtdeux V; Eddarkaoui S; Drobecq H; Ghestem A; Bégard S; Demey-Thomas E; Melnyk P; Smet C; Lippens G; Maurage CA; Caillet-Boudin ML; Verdier Y; Vinh J; Landrieu I; Galas MC; Blum D; Hamdane M; Sergeant N; Buée L
Neurobiol Aging; 2013 Mar; 34(3):757-69. PubMed ID: 22926167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
